- Home
- CDNS vs GSK Comparison
CDNS vs GSK Comparison
Compare CDNS & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNS
- GSK
- Stock Information
- Founded
- CDNS 1988
- GSK 1715
- Country
- CDNS United States
- GSK United Kingdom
- Employees
- CDNS N/A
- GSK N/A
- Industry
- CDNS Computer Software: Prepackaged Software
- GSK Biotechnology: Pharmaceutical Preparations
- Sector
- CDNS Technology
- GSK Health Care
- Exchange
- CDNS Nasdaq
- GSK Nasdaq
- Market Cap
- CDNS 86.1B
- GSK 86.1B
- IPO Year
- CDNS 1987
- GSK N/A
- Fundamental
- Price
- CDNS $295.40
- GSK $38.04
- Analyst Decision
- CDNS Buy
- GSK Hold
- Analyst Count
- CDNS 13
- GSK 3
- Target Price
- CDNS $325.62
- GSK N/A
- AVG Volume (30 Days)
- CDNS 2.1M
- GSK 4.9M
- Earning Date
- CDNS 07-21-2025
- GSK 07-30-2025
- Dividend Yield
- CDNS N/A
- GSK 4.23%
- EPS Growth
- CDNS 2.60
- GSK N/A
- EPS
- CDNS 3.94
- GSK 0.98
- Revenue
- CDNS $4,874,527,000.00
- GSK $40,735,668,430.00
- Revenue This Year
- CDNS $13.96
- GSK $6.70
- Revenue Next Year
- CDNS $11.74
- GSK $5.42
- P/E Ratio
- CDNS $74.98
- GSK $18.78
- Revenue Growth
- CDNS 19.55
- GSK 2.57
- 52 Week Low
- CDNS $221.56
- GSK $31.72
- 52 Week High
- CDNS $328.99
- GSK $44.67
- Technical
- Relative Strength Index (RSI)
- CDNS 45.52
- GSK 40.16
- Support Level
- CDNS $297.03
- GSK $40.67
- Resistance Level
- CDNS $304.44
- GSK $42.63
- Average True Range (ATR)
- CDNS 5.99
- GSK 0.66
- MACD
- CDNS -1.17
- GSK -0.41
- Stochastic Oscillator
- CDNS 38.95
- GSK 4.67
About CDNS Cadence Design Systems Inc.
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.